Abstract
Background
Several studies have examined the role of ursodeoxycholic acid (UDCA) for the prevention of cholelithiasis (gallstones) following rapid weight loss from restrictive diets, vertical band gastroplasty, and Roux-en-Y gastric bypass. However, to date, there have been no prospective, controlled studies examining the role of UDCA for the prevention of gallstones following sleeve gastrectomy (SG). This study was conducted to identify the effectiveness of UDCA for prevention of gallstones after SG.
Methods
Following SG, eligible patients were randomized to a control group who did not receive UDCA treatment or to a group who were prescribed 300 mg UDCA twice daily for 6 months. Gallbladder ultrasounds were performed preoperatively and at 6 and 12 months postoperatively. Patients with positive findings preoperatively were excluded from the study. Compliance with UDCA was assessed.
Results
Between December 2011 and April 2013, 37 patients were randomized to the UDCA treatment arm and 38 patients were randomized to no treatment. At baseline, the two groups were similar. At 6 months, the UDCA group had a statistically significant lower incidence of gallstones (p = 0.032). Analysis revealed no significant difference in gallstones between the two groups at 1 year (p = 0.553 and p = 0.962, respectively). The overall gallstone formation rate was 29.8 %.
Conclusions
The incidence of gallstones is higher than previously estimated in SG patients. UDCA significantly lowers the gallstone formation rate at 6 months postoperatively.
Similar content being viewed by others
References
Lewis CE, Dhanasopon A, Dutson EP, et al. Early experience with laparoscopic sleeve gastrectomy as a single-stage bariatric procedure. Am Surg. 2009;75:945–49.
Nguyen NT, Nguyen B, Gebhart A, et al. Changes in the makeup of bariatric surgery: a national increase in use of laparoscopic sleeve gastrectomy. J Am Coll Surg. 2013;216:252–57.
Abbatini F, Rizzello M, Casella G, et al. Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc. 2010;24:1005–10.
Lee CM, Cirangle PT, Jossart GH. Vertical gastrectomy in 216 patients: report of two-year results. Surg Endosc. 2007;21:1810–16.
Roa PE, Kaaidar- Person O, Pinto D, et al. Laparascopic sleeve gastrectomy as treatment for morbid obesity: technique and short-term outcome. Obes Surg. 2006;16:1323–26.
Brandao I, de Oliveira C, Adami Chaim E, et al. Impact of rapid weight reduction on risk of cholelithiasis after bariatric surgery. Obes Surg. 2003;13:625–8.
Abo-Ryia MH, Abd-Allah HS, El-Khadrawy OH, et al. Predictors of gallstone formation in morbidly obese patients after bariatric surgery: a retrospective observational study. Surg Sci. 2014;5:1–5.
Li VKM, Pulido N, Fajnwaks P, et al. Predictors of gallstone formation after bariatric surgery: a multivariate analysis of risk factors comparing gastric bypass, gastric banding, and sleeve gastrectomy. Surg Endosc. 2009;23:1640–44.
Sioka E, Zacharoulis D, Zachari E, Papamargaritis D, Pinaka O, Katsogridaki G, et al. Complicated gallstones after laparoscopic sleeve gastrectomy. J Obes. 2014;468203
Villegas L, Schneider B, Provost D, et al. Is routine cholecystectomy required during laparoscopic gastric bypass? Obes Surg. 2004;14(2):206–11.
Sugerman HJ, Brewer WH, Shiffman ML, et al. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg. 1995;169(1):91–6.
Williams CN, Gowan R, Perey BJ. A double-blind placebo-controlled trial of ursodeoxycholic acid in the prevention of gallstones during weight loss after vertical band gastroplasty. Obes Surg. 1993;3:257–9.
Worobetz LJ, Inglis FG, Shaffer EA. The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss. Am J Gastroenterol. 1993;88(10):1705–10.
Miller K, Hell E, Lang B, et al. Gallstone formation prophylaxis after gastric restrictive procedures for weight loss. Ann Surg. 2003;238:697–702.
Gourash WF, Ebel F, Lancaster K, et al. Longitudinal assessment of bariatric surgery (LABS): retention strategy and results at 24 months. Surg Obes Relat Dis. 2013;9:514–9.
Shiffman ML, Shamburek RD, Schwartz CC, et al. Gallbladder mucin, arachidonic acid, and bile lipids in patients who develop gallstones during weight reduction. Gastroenterology. 1993;105:1200–8.
Jamal M, Wegner R, Heitshusen D, et al. Resolution of hyperlipidemia follows surgical weight loss in patients undergoing Roux-en-Y gastric bypass surgery: a 6 year analysis of data. Surg Obes Rel Dis. 2011;7:473–79.
Vix M, Diana M, Liu KH, et al. Evolution of glycolipid profile after sleeve gastrectomy vs. Roux-en-Y gastric bypass: results of a prospective randomized clinical trial. Obes Surg. 2013;23:613–21.
Reuben A, Qureshi Y, Murphy GM, et al. Effect of obesity and weight reduction on biliary cholesterol saturation and the response to chenodeoxycholic acid. Eur J Clin Invest. 1986;16:133–42.
Schlierf G, Schellenberg B, Stiehl A, et al. Biliary cholesterol saturation and weight reduction-effects of fasting and low calorie diet. Digestion. 1981;21:44–9.
Marzio L, Capone F, Neri M, et al. Gallbladder kinetics in obese patients: effect of a regular meal and low-calorie meal. Dig Dis Sci. 1988;22:4–9.
Fisher RS, Rock E, Malmud LS. Effects of meal composition on gallbladder and gastric emptying in man. Dig Dis Sci. 1987;32:1337–44.
Thompson RS, Rivara FP, Thompson DC. Ursodeoxycholic acid and gallstones during weight loss. N Engl J Med. 1989;320:1351–53.
Stone BG, Ansel HJ, Peterson FJ, et al. Gallbladder emptying stimuli in obese and normal-weight subjects. Hepatology. 1992;15:795–9.
D’Hondt M, Sergeant G, Deylgat B, et al. Prophylactic cholecystectomy, a mandatory step in morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass? J Gastrointest Surg. 2011;5:1532–36.
Quesada BM, Kohan G, Roff HE, et al. Management of gallstones and gallbladder disease in patients undergoing gastric bypass. World J Gastroenterol. 2010;16:2075–79.
Li VKM, Pulido N, Martinez-Suartez P, et al. Symptomatic gallstones after sleeve gastrectomy. Surg Endosc. 2009;23:2488–92.
Miller K, Hell E, Lang B, et al. Gallstone formation prophylaxis after gastric restrictive procedures for weight loss: a randomized double-blind placebo-controlled trial. Ann Surg. 2003;238:697–70.
Conflict of Interest
The authors declare that they have no competing interests.
Compliance with Ethical Standards
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
Additional informed consent was obtained from all individual participants for whom identifying information is included in this article (does not apply).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Adams, L.B., Chang, C., Pope, J. et al. Randomized, Prospective Comparison of Ursodeoxycholic Acid for the Prevention of Gallstones after Sleeve Gastrectomy. OBES SURG 26, 990–994 (2016). https://doi.org/10.1007/s11695-015-1858-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-015-1858-5